Researchers reviewed existing data on the neurodegenerative effects of astrocyte-derived lipocalin-2 (LCN-2).
Canopy Growth Raises $35 Million Selling Units
Canopy Growth Announces Upsized US$35 Million Private Placement SMITHS FALLS, ON, Jan. 18, 2024 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: